2016
DOI: 10.1155/2016/5079675
|View full text |Cite
|
Sign up to set email alerts
|

Pregabalin for Refractory Radicular Leg Pain due to Lumbar Spinal Stenosis: A Preliminary Prospective Study

Abstract: We investigated the efficacy of pregabalin (PGB) for neuropathic leg pain in lumbar spinal stenosis (LSS) patients with disturbed activities of daily living (ADL)/quality of life (QOL) in a prospective observational study. Subjects were a total of 104 LSS patients with neuropathic pain (NeP) in leg and neurological intermittent claudication (IMC) refractory to nonsteroidal anti-inflammatory drugs (NSAIDs) for at least a month. NeP was identified using screening tool, Pain DETECT questionnaire. Visual analog sc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
25
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(26 citation statements)
references
References 36 publications
(35 reference statements)
1
25
0
Order By: Relevance
“…Patients with lumbar disc herniation usually present symptoms like pain, numbness, and weakness, which have a negative influence on their social functions [1,16]. Our results showed that 75 (87.2%) out of 86 patients had pain, 61 patients (70.9%) had numbness, and only 37 patients (43%) had weakness.…”
Section: Discussionmentioning
confidence: 64%
“…Patients with lumbar disc herniation usually present symptoms like pain, numbness, and weakness, which have a negative influence on their social functions [1,16]. Our results showed that 75 (87.2%) out of 86 patients had pain, 61 patients (70.9%) had numbness, and only 37 patients (43%) had weakness.…”
Section: Discussionmentioning
confidence: 64%
“…Neuropathic pain medications can be helpful in improving the standing and walking intolerance for patients with symptomatic LSS. A study of the use of pregabalin in 104 patients with intermittent neurogenic claudication unresponsive to NSAIDs for at least a month demonstrated an improvement in VAS and Japanese Orthopedic Association Back Pain Evaluation Questionnaire scores at 6 weeks’ follow‐up . It should be noted that the side effect profile of central nervous system (CNS) active drugs can be difficult to tolerate in many patients in the LSS age group.…”
Section: Therapies To Consider For the Treatment Algorithmmentioning
confidence: 99%
“…A study of the use of pregabalin in 104 patients with intermittent neurogenic claudication unresponsive to NSAIDs for at least a month demonstrated an improvement in VAS and Japanese Orthopedic Association Back Pain Evaluation Questionnaire scores at 6 weeks' follow-up. 42 It should be noted that the side effect profile of central nervous system (CNS) active drugs can be difficult to tolerate in many patients in the LSS age group. Lubelski et al 43 demonstrated, in a retrospective review of over 1,300 patients, that the prediction of quality-of-life (QOL) improvements in patients with LSS treated with membrane-stabilizing agents (MSAs) is associated with 4 categories: need for surgery within 1 year of initiation, time of surgery after initiation, improvement in QOL based on the EuroQol 5 dimensions questionnaire (EQ-5D) QOL index, and improvement in EQ-5D score.…”
Section: Pharmacologic Optionsmentioning
confidence: 99%
“…It is combined with muscular discomfort that can be improved by rest or changing position [1,5]. Final pathologies underlying pain in CLSS patients are neurological damage to the spinal nerve compression and cauda equina [6]. CLSS is characterized by lumbar spinal canal narrowing that is caused by proliferation of the superior articular process, mechanical compression of the spinal nerve roots, hyperostosis of the vertebral posterior border, a hypertrophied ligamentum flavum, and protrusion of the intervertebral disc [7].…”
Section: Introductionmentioning
confidence: 99%